CA - Appili Therapeutics GAAP EPS of -C$0.04 November, 10 2022 09:46 AM CA Inc. Appili Therapeutics press release ( OTCQX:APLIF ): Q2 GAAP EPS of -C$0.04. As of September 30, 2022, the Company had cash of C$2.4 million, compared to C$6.7 million on March 31, 2022. For further details see: Appili Therapeutics GAAP EPS of -C$0.04